Literature DB >> 136325

Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukaemia (CLL).

N K Day, J B Winfield, T Gee, R Winchester, H Teshima, H G Kunkel.   

Abstract

Unmeasurable total haemolytic complement (C) was observed in serum of a patient with untreated chronic lymphocytic leukaemia and recurrent non-hereditary angioedema. Analysis of C components immunochemically demonstrated a marked reduction of C1q and C1s inhibitor, undetectable C1r, C1s and an elevated B. Haemolytic C1, C4 and C2 were less than 5 percent of normal, functional C1s inhibitor was absent. Cryoglobulin and C1q precipitins were present in the serum. Of special interest was the presence of high levels of cold-reactive antilymphocyte antibody, determined by both C-dependent cytotoxicity and indirect immunofluorescence. The antibody exhibited specificities for both autologous lymphocytes and lymphocytes from normal donors; cytotoxic activity for autologous leukaemia cells was removed by absorption with normal isologous tonsil lymphocytes. Specific enrichment of this antibody relative to the serum level was demonstrated in the cryoglobulin and its isolated 19S fractions. Free lymphocyte surface antigen was also demonstrated by gel diffusion using specific rabbit antilymphocyte antiserum. These data strongly suggest the presence of pathogenetically significant circulating complexes of lymphocyte surface antigen and specific antibody in certain patients with CLL.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 136325      PMCID: PMC1540857     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

2.  Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.

Authors:  O Götze; H J Müller-Eberhard
Journal:  N Engl J Med       Date:  1972-01-27       Impact factor: 91.245

3.  Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.

Authors:  M Ballow; C G Cochrane
Journal:  J Immunol       Date:  1969-11       Impact factor: 5.422

4.  Specific concentration of antilymphocyte antibodies in the serum cryoprecipitates of patients with systemic lupus erythematosus.

Authors:  J B Winfield; R J Winchester; P Wernet; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

5.  Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus.

Authors:  J B Winfield; R J Winchester; H G Kunkel
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

6.  Complete absence of the third component of complement in man.

Authors:  M Ballow; J E Shira; L Harden; S Y Yang; N K Day
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

7.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

8.  The association of respiratory infection, recurrent hematuria, and focal glomerulonephritis with activation of the complement system in the cold.

Authors:  N K Day; H Geiger; R McLean; J Resnick; A Michael; R A Good
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

9.  Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus.

Authors:  J B Winfield; R J Winchester; P Wernet; S M Fu; H G Kunkel
Journal:  Arthritis Rheum       Date:  1975 Jan-Feb

10.  C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum.

Authors:  A T Sobel; V A Bokisch; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

  10 in total
  18 in total

1.  Complement activation profiles in disease.

Authors:  D L Brown
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement.

Authors:  J A Schifferli; M Pascual; G Steiger; M Schapira; J E Ryser; J Estreicher; A Dash
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

4.  Cycling of peripheral blood and marrow lymphocytes in cyclic neutropenia.

Authors:  D Engelhard; K S Landreth; N Kapoor; P W Kincade; L E De Bault; A Theodore; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

5.  Self-nonself concept for cancer and diseases previously known as "autoimmune" diseases (illegitimate transferases/plasma exchange).

Authors:  P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

6.  Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.

Authors:  H Teshima; H Wanebo; C Pinsky; N K Day
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

7.  Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.

Authors:  W E Brandeis; C Tan; Y Wang; R A Good; N K Day
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

8.  Depressed classical complement pathway activities in chronic lymphocytic leukaemia.

Authors:  G Füst; E Czink; D Minh; Z Miszlay; L Varga; S R Hollán
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  Circulating immune complexes in sera of children with neuroblastoma: correlation with stage of disease.

Authors:  W E Brandeis; L Helson; Y Wang; R A Good; N K Day
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

10.  Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy.

Authors:  G Hauptmann; F Petitjean; J M Lang; F Oberling
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.